Premium
CLINICAL OUTCOMES OF PATIENTS WITH INTERMEDIATE‐TO‐HIGH‐RISK FOLLICULAR LYMPHOMA (FL) IN THE GALLIUM PHASE III STUDY
Author(s) -
Laun A.,
Casulo C.,
Pott C.,
Rusconi C.,
Hernandez J.,
Davies A.J.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.56_2631
Subject(s) - medicine , follicular lymphoma , international prognostic index , bendamustine , rituximab , obinutuzumab , hazard ratio , surgery , population , oncology , lymphoma , confidence interval , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom